• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人精氨酸酶 I 的底物和产物类似物的抑制作用。

Inhibition of human arginase I by substrate and product analogues.

机构信息

Roy and Diana Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104-6323, USA.

出版信息

Arch Biochem Biophys. 2010 Apr 15;496(2):101-8. doi: 10.1016/j.abb.2010.02.004. Epub 2010 Feb 12.

DOI:10.1016/j.abb.2010.02.004
PMID:20153713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2850953/
Abstract

Human arginase I is a binuclear manganese metalloenzyme that catalyzes the hydrolysis of L-arginine to generate L-ornithine and urea. We demonstrate that N-hydroxy-L-arginine (NOHA) binds to this enzyme with K(d)=3.6 microM, and nor-N-hydroxy-L-arginine (nor-NOHA) binds with K(d)=517 nM (surface plasmon resonance) or K(d) approximately 50 nM (isothermal titration calorimetry). Crystals of human arginase I complexed with NOHA and nor-NOHA afford 2.04 and 1.55 A resolution structures, respectively, which are significantly improved in comparison with previously-determined structures of the corresponding complexes with rat arginase I. Higher resolution structures clarify the binding interactions of the inhibitors. Finally, the crystal structure of the complex with L-lysine (K(d)=13 microM) is reported at 1.90 A resolution. This structure confirms the importance of hydrogen bond interactions with inhibitor alpha-carboxylate and alpha-amino groups as key specificity determinants of amino acid recognition in the arginase active site.

摘要

人源精氨酸酶 I 是一种双核锰金属酶,能够催化 L-精氨酸水解生成 L-鸟氨酸和尿素。我们证明 N-羟基-L-精氨酸(NOHA)与该酶的结合常数为 Kd=3.6 μM,而 nor-N-羟基-L-精氨酸(nor-NOHA)的结合常数为 Kd=517 nM(表面等离子体共振)或 Kd 约为 50 nM(等温滴定量热法)。与先前测定的大鼠精氨酸酶 I 相应复合物的结构相比,NOHA 和 nor-NOHA 与人源精氨酸酶 I 复合物的晶体分别达到了 2.04 和 1.55Å的分辨率,结构得到了显著改善。更高分辨率的结构阐明了抑制剂的结合相互作用。最后,报道了 L-赖氨酸(Kd=13 μM)复合物的晶体结构,分辨率为 1.90Å。该结构证实了与抑制剂 α-羧基和 α-氨基的氢键相互作用对于精氨酸酶活性部位中氨基酸识别的特异性决定因素的重要性。

相似文献

1
Inhibition of human arginase I by substrate and product analogues.人精氨酸酶 I 的底物和产物类似物的抑制作用。
Arch Biochem Biophys. 2010 Apr 15;496(2):101-8. doi: 10.1016/j.abb.2010.02.004. Epub 2010 Feb 12.
2
Mechanistic and metabolic inferences from the binding of substrate analogues and products to arginase.基于底物类似物和产物与精氨酸酶结合的机制及代谢推断
Biochemistry. 2001 Mar 6;40(9):2689-701. doi: 10.1021/bi002318+.
3
L-arginine binding to liver arginase requires proton transfer to gateway residue His141 and coordination of the guanidinium group to the dimanganese(II,II) center.L-精氨酸与肝脏精氨酸酶的结合需要质子转移至门户残基His141,并使胍基与二锰(II,II)中心配位。
Biochemistry. 1998 Jun 9;37(23):8539-50. doi: 10.1021/bi972874c.
4
Inhibitor coordination interactions in the binuclear manganese cluster of arginase.精氨酸酶双核锰簇中的抑制剂配位相互作用。
Biochemistry. 2004 Jul 20;43(28):8987-99. doi: 10.1021/bi0491705.
5
Crystal structures of Bacillus caldovelox arginase in complex with substrate and inhibitors reveal new insights into activation, inhibition and catalysis in the arginase superfamily.嗜热栖热芽孢杆菌精氨酸酶与底物及抑制剂复合物的晶体结构揭示了精氨酸酶超家族中激活、抑制和催化作用的新见解。
Structure. 1999 Apr 15;7(4):435-48. doi: 10.1016/s0969-2126(99)80056-2.
6
Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages.新型精氨酸酶抑制剂N(ω)-羟基-L-精氨酸对小鼠巨噬细胞中一氧化氮合酶活性的影响
Nitric Oxide. 1999 Dec;3(6):427-38. doi: 10.1006/niox.1999.0255.
7
Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158.关于人精氨酸酶-1的pH依赖性及其被小分子抑制剂CB-1158抑制的结构见解。
J Struct Biol X. 2019 Nov 26;4:100014. doi: 10.1016/j.yjsbx.2019.100014. eCollection 2020.
8
N omega-hydroxyl-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase.Nω-羟基-L-精氨酸是L-精氨酸转化为一氧化氮途径中的一种中间体,是肝脏和巨噬细胞精氨酸酶的强效抑制剂。
Biochem Biophys Res Commun. 1994 Sep 30;203(3):1614-21. doi: 10.1006/bbrc.1994.2371.
9
Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum.探究勃起功能:S-(2-硼乙基)-L-半胱氨酸作为过渡态类似物与精氨酸酶结合,并增强人阴茎海绵体平滑肌松弛。
Biochemistry. 2001 Mar 6;40(9):2678-88. doi: 10.1021/bi002317h.
10
Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections.墨西哥利什曼原虫精氨酸酶的晶体结构及其对寄生虫感染中多胺生物合成抑制的影响。
Arch Biochem Biophys. 2013 Jul 15;535(2):163-76. doi: 10.1016/j.abb.2013.03.015. Epub 2013 Apr 9.

引用本文的文献

1
Promotion of nitric oxide production: mechanisms, strategies, and possibilities.一氧化氮生成的促进:机制、策略及可能性
Front Physiol. 2025 Jan 23;16:1545044. doi: 10.3389/fphys.2025.1545044. eCollection 2025.
2
Synthesis of Arginase Inhibitors: An Overview.精氨酸酶抑制剂的合成:综述
Pharmaceutics. 2025 Jan 16;17(1):117. doi: 10.3390/pharmaceutics17010117.
3
Pathophysiology of Arginases in Cancer and Efforts in Their Pharmacological Inhibition.精氨酸酶在癌症中的病理生理学及其药物抑制作用的研究进展。
Int J Mol Sci. 2024 Sep 10;25(18):9782. doi: 10.3390/ijms25189782.
4
Metabolome and transcriptome integration reveals cerebral cortical metabolic profiles in rats with subarachnoid hemorrhage.代谢组学与转录组学整合揭示蛛网膜下腔出血大鼠的大脑皮质代谢谱。
Front Aging Neurosci. 2024 Aug 21;16:1424312. doi: 10.3389/fnagi.2024.1424312. eCollection 2024.
5
Therapeutic Modulation of Arginase with nor-NOHA Alters Immune Responses in Experimental Mouse Models of Pulmonary Tuberculosis including in the Setting of Human Immunodeficiency Virus (HIV) Co-Infection.用去甲-N-羟基-L-精氨酸对精氨酸酶进行治疗性调节可改变肺结核实验小鼠模型中的免疫反应,包括在人类免疫缺陷病毒(HIV)合并感染的情况下。
Trop Med Infect Dis. 2024 Jun 6;9(6):129. doi: 10.3390/tropicalmed9060129.
6
Arginase inhibitory activities of guaiane sesquiterpenoids from Curcuma comosa rhizomes.莪术根茎中倍半萜类化合物的精氨酸酶抑制活性。
J Nat Med. 2023 Sep;77(4):891-897. doi: 10.1007/s11418-023-01731-9. Epub 2023 Jul 18.
7
In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators.通过计算机模拟研究来识别将精氨酸酶-I抑制剂重新用作潜在肿瘤免疫调节剂的疗法。
Front Pharmacol. 2023 Apr 18;14:1129997. doi: 10.3389/fphar.2023.1129997. eCollection 2023.
8
Inhibiting Human and Arginases Using as a Potential Therapy for Cutaneous Leishmaniasis: A Molecular Docking Study.使用[具体物质]抑制人精氨酸酶作为皮肤利什曼病的潜在治疗方法:一项分子对接研究
Trop Med Infect Dis. 2022 Nov 26;7(12):400. doi: 10.3390/tropicalmed7120400.
9
Arginase: Biological and Therapeutic Implications in Diabetes Mellitus and Its Complications.精氨酸酶:在糖尿病及其并发症中的生物学和治疗意义。
Oxid Med Cell Longev. 2022 Oct 26;2022:2419412. doi: 10.1155/2022/2419412. eCollection 2022.
10
Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases.精氨酸酶:揭示心血管疾病的机制与机遇
Cell Death Discov. 2022 Oct 8;8(1):413. doi: 10.1038/s41420-022-01200-4.

本文引用的文献

1
Nitric Oxide: Chemical Puzzles Posed by a Biological Messenger.一氧化氮:一种生物信使引发的化学谜题。
Angew Chem Int Ed Engl. 1999 Jun 14;38(12):1714-1731. doi: 10.1002/(SICI)1521-3773(19990614)38:12<1714::AID-ANIE1714>3.0.CO;2-3.
2
Recent advances in arginine metabolism: roles and regulation of the arginases.精氨酸代谢的最新进展:精氨酸酶的作用和调节。
Br J Pharmacol. 2009 Jul;157(6):922-30. doi: 10.1111/j.1476-5381.2009.00278.x. Epub 2009 Jun 5.
3
Amide-pi interactions between formamide and benzene.甲酰胺和苯之间的酰胺-π 相互作用。
J Comput Chem. 2009 Nov 15;30(14):2267-76. doi: 10.1002/jcc.21212.
4
Probing the specificity determinants of amino acid recognition by arginase.探究精氨酸酶识别氨基酸的特异性决定因素。
Biochemistry. 2009 Jan 13;48(1):121-31. doi: 10.1021/bi801911v.
5
(S)-2-amino-6-nitrohexanoic acid binds to human arginase I through multiple nitro-metal coordination interactions in the binuclear manganese cluster.(S)-2-氨基-6-硝基己酸通过双核锰簇中的多种硝基-金属配位相互作用与人精氨酸酶I结合。
J Am Chem Soc. 2008 Dec 24;130(51):17254-5. doi: 10.1021/ja807702q.
6
Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation.精氨酸酶抑制可预防变应原诱导的气道阻塞、高反应性和炎症。
Am J Respir Crit Care Med. 2008 Sep 15;178(6):565-73. doi: 10.1164/rccm.200710-1588OC. Epub 2008 Jun 26.
7
Evolution of the arginase fold and functional diversity.精氨酸酶折叠结构的演变与功能多样性。
Cell Mol Life Sci. 2008 Jul;65(13):2039-55. doi: 10.1007/s00018-008-7554-z.
8
Crystal structure of human arginase I complexed with thiosemicarbazide reveals an unusual thiocarbonyl mu-sulfide ligand in the binuclear manganese cluster.与氨基硫脲复合的人精氨酸酶I的晶体结构揭示了双核锰簇中一种不寻常的硫代羰基μ-硫化物配体。
J Am Chem Soc. 2007 May 23;129(20):6388-9. doi: 10.1021/ja071567j. Epub 2007 May 1.
9
Role of the L-citrulline/L-arginine cycle in iNANC nerve-mediated nitric oxide production and airway smooth muscle relaxation in allergic asthma.L-瓜氨酸/L-精氨酸循环在过敏性哮喘中诱导型非肾上腺素能非胆碱能(iNANC)神经介导的一氧化氮生成及气道平滑肌舒张中的作用
Eur J Pharmacol. 2006 Sep 28;546(1-3):171-6. doi: 10.1016/j.ejphar.2006.07.041. Epub 2006 Jul 27.
10
Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response.人精氨酸酶I 1.29埃分辨率的晶体结构及免疫反应中抑制作用的探索。
Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13058-63. doi: 10.1073/pnas.0504027102. Epub 2005 Sep 2.